How can we better manage drug-resistant OAB/DO? ICI-RS 2018.
Christopher J ChermanskyBrigitte SchurchMohammad Sajjad RahnamaiMarcio Augusto AverbeckSachin MaldeVito ManciniFrancoise ValentiniArun SahaiPublished in: Neurourology and urodynamics (2020)
Further research is required to optimize these procedures and to better understand which patients will benefit from the various options available in managing refractory OAB.